Iconic Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Phase 2
Terminated
- Conditions
- Choroidal NeovascularizationWet Macular Degeneration
- Interventions
- Biological: ICON-1Biological: aflibercept
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Iconic Therapeutics, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03452527
- Locations
- 🇺🇸
Site 2, Beverly Hills, California, United States
🇺🇸Site 8, Santa Ana, California, United States
🇺🇸Site 7, Syracuse, New York, United States
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Phase 1
Completed
- Conditions
- Uveal MelanomaChoroid Neoplasm
- Interventions
- Biological: ICON-1
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Iconic Therapeutics, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02771340
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Phase 2
Completed
- Conditions
- Age-related Macular DegenerationChoroidal Neovascularization
- Interventions
- Biological: hI-con1Biological: ranibizumabOther: Sham injection
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2020-09-24
- Lead Sponsor
- Iconic Therapeutics, Inc.
- Target Recruit Count
- 88
- Registration Number
- NCT02358889
Safety and Tolerability Study for Age-Related Macular Degeneration
Phase 1
Completed
- Conditions
- Neovascular Age-Related Macular Degeneration
- Interventions
- Drug: hI-con1™ 150µlDrug: hI-con1™ 300µlDrug: hI-con1™ 60µl
- First Posted Date
- 2011-12-05
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Iconic Therapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01485588
- Locations
- 🇺🇸
Rocky Mountain Eye Center, P.C., Missoula, Montana, United States
🇺🇸Retina & Vitreous Center of Southern Oregon, P.C., Ashland, Oregon, United States
🇺🇸Palmetto Retina Center, West Columbia, South Carolina, United States